9FDA
 
 | |
9FCO
 
 | Structure of E. coli 30S-IF1-IF3-mRNA-Kasugamycin complex | Descriptor: | (1S,2R,3S,4R,5S,6S)-2,3,4,5,6-PENTAHYDROXYCYCLOHEXYL 2-AMINO-4-{[CARBOXY(IMINO)METHYL]AMINO}-2,3,4,6-TETRADEOXY-ALPHA-D-ARABINO-HEXOPYRANOSIDE, 16S rRNA, MAGNESIUM ION, ... | Authors: | Safdari, H.A, Wilson, D.N. | Deposit date: | 2024-05-15 | Release date: | 2025-03-19 | Method: | ELECTRON MICROSCOPY (2.4 Å) | Cite: | The translation inhibitors kasugamycin, edeine and GE81112 target distinct steps during 30S initiation complex formation. Nat Commun, 16, 2025
|
|
9G06
 
 | Structure of 30S-IF1-IF3-mRNA-fMet-tRNA-GE81112A complex | Descriptor: | (2S,3S)-2-[[(2S)-2-[[(2S,4S)-5-aminocarbonyloxy-4-oxidanyl-2-[[(2S,3R)-3-oxidanylpiperidin-2-yl]carbonylamino]pentanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-(2-chloranyl-1H-imidazol-4-yl)-3-oxidanyl-propanoic acid, 16S ribosomal RNA, MAGNESIUM ION, ... | Authors: | Safdari, H.A, Morici, M, Wilson, D.N. | Deposit date: | 2024-07-07 | Release date: | 2025-03-19 | Method: | ELECTRON MICROSCOPY (2.85 Å) | Cite: | The translation inhibitors kasugamycin, edeine and GE81112 target distinct steps during 30S initiation complex formation. Nat Commun, 16, 2025
|
|
9FIB
 
 | Structure of 30S-IF1-IF3-mRNA-GE81112A complex | Descriptor: | (2S,3S)-2-[[(2S)-2-[[(2S,4S)-5-aminocarbonyloxy-4-oxidanyl-2-[[(2S,3R)-3-oxidanylpiperidin-2-yl]carbonylamino]pentanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-(2-chloranyl-1H-imidazol-4-yl)-3-oxidanyl-propanoic acid, 16S rRNA, MAGNESIUM ION, ... | Authors: | Safdari, H.A, Morici, M, Wilson, D.N. | Deposit date: | 2024-05-29 | Release date: | 2025-03-19 | Method: | ELECTRON MICROSCOPY (2.3 Å) | Cite: | The translation inhibitors kasugamycin, edeine and GE81112 target distinct steps during 30S initiation complex formation. Nat Commun, 16, 2025
|
|